SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Weinberg Jonathan – ‘4’ for 8/5/20 re: Evolent Health, Inc.

On:  Friday, 8/7/20, at 8:51pm ET   ·   For:  8/5/20   ·   Accession #:  1642833-20-3   ·   File #:  1-37415

Previous ‘4’:  ‘4’ on 3/4/20 for 3/2/20   ·   Next:  ‘4’ on 3/3/21 for 3/1/21   ·   Latest:  ‘4’ on 3/5/24 for 3/1/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer

 8/07/20  Weinberg Jonathan                 4                      1:7K   Evolent Health, Inc.

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      3K 
                Securities by an Insider --                                      
                wf-form4_159684779432926.xml/3.6


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider — wf-form4_159684779432926.xml/3.6
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<ownershipDocument>
<schemaVersion> X0306 </schemaVersion>
<documentType> 4 </documentType>
<periodOfReport> 2020-08-05 </periodOfReport>
<notSubjectToSection16> 0 </notSubjectToSection16>
<issuer>
<issuerCik> 0001628908 </issuerCik>
<issuerName> Evolent Health, Inc. </issuerName>
<issuerTradingSymbol> EVH </issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik> 0001642833 </rptOwnerCik>
<rptOwnerName> Weinberg Jonathan </rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerStreet1> C/O EVOLENT HEALTH, INC. </rptOwnerStreet1>
<rptOwnerStreet2> 800 N. GLEBE ROAD, SUITE 500 </rptOwnerStreet2>
<rptOwnerCity> ARLINGTON </rptOwnerCity>
<rptOwnerState> VA </rptOwnerState>
<rptOwnerZipCode> 22203 </rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector> 0 </isDirector>
<isOfficer> 1 </isOfficer>
<isTenPercentOwner> 0 </isTenPercentOwner>
<isOther> 0 </isOther>
<officerTitle> General Counsel </officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value> Class A Common Stock </value>
</securityTitle>
<transactionDate>
<value> 2020-08-05 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> M </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
<footnoteId id="F1"/>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 10000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 3.84 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> A </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 76775 </value>
<footnoteId id="F2"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
<nonDerivativeTransaction>
<securityTitle>
<value> Class A Common Stock </value>
</securityTitle>
<transactionDate>
<value> 2020-08-05 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> S </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
<footnoteId id="F1"/>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 10000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 13.01 </value>
<footnoteId id="F3"/>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> D </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 66775 </value>
<footnoteId id="F2"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<derivativeTable>
<derivativeTransaction>
<securityTitle>
<value> Class A Common Stock Option (right to buy) </value>
</securityTitle>
<conversionOrExercisePrice>
<value> 3.84 </value>
</conversionOrExercisePrice>
<transactionDate>
<value> 2020-08-05 </value>
</transactionDate>
<transactionCoding>
<transactionFormType> 4 </transactionFormType>
<transactionCode> M </transactionCode>
<equitySwapInvolved> 0 </equitySwapInvolved>
<footnoteId id="F1"/>
</transactionCoding>
<transactionAmounts>
<transactionShares>
<value> 10000 </value>
</transactionShares>
<transactionPricePerShare>
<value> 0 </value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value> D </value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<exerciseDate>
<footnoteId id="F4"/>
</exerciseDate>
<expirationDate>
<value> 2024-04-01 </value>
</expirationDate>
<underlyingSecurity>
<underlyingSecurityTitle>
<value> Class A Common Stock </value>
</underlyingSecurityTitle>
<underlyingSecurityShares>
<value> 10000.0 </value>
</underlyingSecurityShares>
</underlyingSecurity>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value> 45431 </value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value> D </value>
</directOrIndirectOwnership>
</ownershipNature>
</derivativeTransaction>
</derivativeTable>
<footnotes>
<footnote id="F1"> The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2020. </footnote>
<footnote id="F2"> Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. </footnote>
<footnote id="F3"> The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.000 to $13.015, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote </footnote>
<footnote id="F4"> The Class A Common Stock Options exercised vested on February 1, 2017. </footnote>
</footnotes>
<remarks></remarks>
<ownerSignature>
<signatureName> /s/ Jonathan Weinberg </signatureName>
<signatureDate> 2020-08-06 </signatureDate>
</ownerSignature>
</ownershipDocument>


↑Top
Filing Submission 0001642833-20-000003   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 9:19:43.2pm ET